NextGen Biomed 2025, London, UK, March 12-14, 2025
Conference
Event
-
February 26, 2025
genOway's presentation on Thursday, March 13, 2025 | 4.30 p.m. GMT:
How to enhance translatability of immunotherapies in preclinical models
- Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Demonstrating the recruitment of human immune cells to the affected area, as well as their activation status
- Highlighting the key role of myeloid compartment in the translatable assessment of biologic's safety in humanized models
Come visit us at Booth #22!
If you'd like to get in touch, fill out the contact form below
NextGen Biomed 2025, London, UK, March 12-14, 2025
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Tailor-made solutions adapted to scientific questions
Robust validation data on catalog models
Comprehensive dataset package
Generated with biopharma partners and in-house
Customer care
Scientific follow-up and advice along the project
Collaborative approach for problem solving and development of innovative models
Easy and fast access to models
Breeding facilities in US and Europe
Certified health status from professional breeders